FDA Approves AMPICILLIN AND SULBACTAM — WG Critical Care, LLC

WG Critical Care, LLC announces the FDA approval of their injectable generic ampicillin and sulbactam powder for intramuscular injection, supplementing the brand's existing intravenous dosage form to offer a broader selection for treating serious infections. This combined notification allows the manufacturer to broaden its portfolio in the hospital setting, creating new competition that supports the class price structure.